Influence of Sampling and Storage Conditions on B-Type Natriuretic Peptide Immunoreactivity for 3 Automated Assays
To the Editor: B-Type natriuretic peptide (BNP) is a marker for diagnosis and prognosis of congestive heart failure (CHF). In response to the analytical uncertainties of automated BNP assays, the IFCC Committee on Standardization of Markers of Cardiac Damage published recommendations for the evaluation of in vitro BNP stability (1 ) .
We analyzed the effect of exposure to room temperature for 24 h on whole-blood BNP immunoreactivity or the effect of 1 freeze-thaw (FT) cycle on plasma BNP immunoreactivity in 3 different assays. Blood samples from 4 CHF patients were collected on ice with Sarstedt tubes containing potassium EDTA (1.6 mg/mL EDTA), EDTA with aprotinin (500 kallikrein-inhibitory units/ mL), and EDTA with benzamidine (80 mol/mL). Whole blood was split into 2 aliquots: one was centrifuged (2400g for 10 min) for immediate assay (baseline), with the remaining plasma stored at Ϫ20°C; the other aliquot was allowed to stand at room temperature for 24 h under constant gentle mixing before centrifugation and assay. The procedure generated a total of 36 aliquots. BNP recoveries were calculated as percentage of baseline.
Baseline BNP values were 1133-4854 ng/L (mean, 1789 ng/L) with the AxSYM (Abbott Diagnostics), 593-3232 ng/L (mean, 1106 ng/L) with the ADVIA Centaur (Bayer Diagnostics), and 540-3839 ng/L (mean, 1359 ng/L) with the Beckman Coulter Access 2 (BioSite reagents). These values were not affected by protease inhibitors (one-way ANOVA for effect of protease inhibitors, P ϭ 0.93, 0.92, and 0.95 for the AxSYM, Centaur, and Access 2, respectively). Exposure of whole blood to room temperature for 24 h led to a mean decrease of 21%. Neither the sampling conditions nor the assay affected BNP loss ( We also evaluated BNP stability during shorter storage times (room temperature and 4°C), without agitation, using conditions close to those likely to be used with samples from outpatient clinics or physicians' offices. EDTA samples from 5 CHF patients with baseline BNP values of 404-2746 ng/L (mean, 1623 ng/L) on the AxSYM, 232-1694 ng/L (mean, 933 ng/L) on the Centaur, and 234-1917 ng/L (mean, 985 ng/L) on the Access 2 were split and allowed to stand at room temperature and 4°C for 4 and 8 h before centrifugation and assay. At room temperature, mean (SD) measured values after 4 h were 88 (8)%, 94 (6)%, and 94 (6)% of the baseline values on the AxSYM, Centaur and Access 2, respectively, and after 8 h, the measured concentrations were 85 (14)%, 91 (7)%, and 89 (6)% of baseline values. At 4°C, after storage for 4 h, measured values were 95 (9)%, 90 (8)%, and 100 (17)% of baseline values on the AxSYM, Centaur, and Access 2, respectively, and after 8 h, they were 90 (10)%, 88 (10)%, and 99 (15)% of baseline values. No significant time or instrument effects were evidenced by ANOVA analysis for storage at room temperature (P ϭ 0.37 and 0.46, respectively) and 4°C (P ϭ 0.48 and 0.22, respectively). The overall loss of BNP reactivity was 10%, a value comparable to the effect of 1 FT cycle. At 4°C, loss of BNP immunoreactivity was somewhat lower, averaging 6%. Our results confirm the AxSYM claim, which was the only package insert (8G82-20) reporting the 4 h BNP stability at room temperature. In contrast, using the Biosite BNP POCT Triage ® meter, Yeo et al. (3 ) reported a significant BNP loss after 4 h of storage at room temperature.
In conclusion, our data indicate that protease inhibition does not pro-tect BNP from degradation at room temperature and that BNP assays can be safely performed within the 8 h after sampling, with whole blood being preferably kept at 4°C, with all 3 instruments tested. (1 ) . We now describe its use and report the agreement of the results with diagnoses in the patient records in this urban teaching hospital 4 years later.
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We queried all BNP orders for June through August 2005 and found 975 test orders on 608 patients. To determine a diagnosis of heart failure, physician discharge dictations and ICD-9 codings were reviewed after Institutional Review Board approval. Final diagnoses were likely influenced by the BNP concentrations in some cases, potentially leading to overestimation of apparent diagnostic accuracy.
The Biosite Triage and Beckman Coulter Access BNP assays were performed according to the manufacturers' guidelines and were highly correlated (r ϭ 0.99; n ϭ 50), with Bland-Altman analysis demonstrating a mean (SD) difference of 16 (23) ng/L. Total imprecision (CV) near the 100 ng/L cutoff was Ͻ12% for both assays.
In 2001, most BNP tests were requested by the emergency department (44%) and cardiology units (41%), noncardiac intensive care unit (ICU; 3.6%), general medicine (3.5%), and miscellaneous clinics (4.1%) (1 ). In 2005, the emergency department ordered 41% and the cardiology units only 10%, diluted by the increase in test utilization by noncardiac ICUs (16%), general medicine units (15%), miscellaneous clinics (13%), cardiology clinics (3.5%), and miscellaneous inpatient services (1.2%; Table 1 ). Thirty percent of patients had a diagnosis of heart failure, and 70% did not. One half (50%) of the group were female. The mean (SD) ages of the heart failure and non-heart failure groups were 63 (15) and 58 (16) years, respectively (P Ͻ0.01). The median (interquartile range) BNP concentration was significantly greater for heart failure patients than for non-heart failure patients [482 (13-1024) ng/L vs 61 (5-161) ng/L, respectively; P Ͻ0.01]. BNP was increased (Ն100 ng/L) in 92.8% of patients with a diagnosis of heart failure and was within reference values in 53.6% of those without heart failure. In patients without a diagnosis of heart failure, 272 BNP tests had values Ն100 ng/L, representing 28% of ordered tests in these patients (without heart failure). Many of these patients had renal, other cardiovascular, pulmonary, or liver disease and/or multisystem pathology, which can also increase BNP. In patients with a diagnosis of heart failure, 28 BNP results were Ͻ100 ng/L. Possible explanations include confounding variables such as 
